.png)
100 IR & 300 IR or 300 IR, sublingual tablets
5-grass pollen allergen extract*
5-grass pollen allergen extract*
At Stallergenes Greer, we partner with Health Care Professionals for patients to live a life beyond allergy,
during and after Allergen
Immunotherapy (AIT)
during and after Allergen
Immunotherapy (AIT)
Go Inside Oralair
*5-grass pollen allergen extract is a mix of cocksfoot (Dactylis glomerata L.), sweet vernal grass (Anthoxanthum
odoratum L.), rye grass (Lolium perenne L.), meadow grass (Poa pratensis L.) and timothy grass (Phleum pratense L.).
odoratum L.), rye grass (Lolium perenne L.), meadow grass (Poa pratensis L.) and timothy grass (Phleum pratense L.).
2022_055_May 2022
.svg)
Oralair® natural 5-grass pollen allergen
extract with an adapted pre-coseasonal
protocol mimics the diverse
real-life exposure of patients
allergic to grass pollen1-3
extract with an adapted pre-coseasonal
protocol mimics the diverse
real-life exposure of patients
allergic to grass pollen1-3
Oralair® is a sublingual
immunotherapy tablet with
a flexible initiation protocol
to improve tolerability
and encourage individual
patient adherence.1,4-7
immunotherapy tablet with
a flexible initiation protocol
to improve tolerability
and encourage individual
patient adherence.1,4-7
Highly potent, Oralair® demonstrated
results as early as 1 month7* and
meaningful improvements over
time for patients to live a life
beyond allergy8,9
results as early as 1 month7* and
meaningful improvements over
time for patients to live a life
beyond allergy8,9
Oralair® has shown long lasting
effectiveness for up to 6 years after
treatment cessation10,11*
effectiveness for up to 6 years after
treatment cessation10,11*
Let's get personal
*Results of the secondary endpoints observed in the controlled conditions of an Allergen Challenge Chamber (ACC). The single allergen source, the lack of seasonal priming, subject demographics closed by the ACC area, trial context and short duration might not reflect the natural pathological process and environmental factors contributing to an individual’s development of allergic rhinoconjunctivitis.
* In this study Oralair was investigated as one product in a treatment group compared to a control group and is based on a retrospective database analysis of health and prescription data
“My name’s Marie. I love my job, but every time spring comes around, my
allergy symptoms hold me back from getting on and achieving all I want to."
Treat her
The following medical history is fictional. The presentation is based on typically occurring
circumstances. The treatment and the success of the therapy depicted represent an idealized
course. This possible course of therapy has been confirmed by clinical studies. Nevertheless, each
patient and each course of disease is highly individual and a corresponding effect cannot be
expected and guaranteed for all patients.
circumstances. The treatment and the success of the therapy depicted represent an idealized
course. This possible course of therapy has been confirmed by clinical studies. Nevertheless, each
patient and each course of disease is highly individual and a corresponding effect cannot be
expected and guaranteed for all patients.
33 years young lady living
in Germany
International journalist
(Italian specialist)
Single, no child, no pets
Passion for Middle East
where she spends holidays
Before
“My name’s Marie. I love my job, but every time
spring comes around, my allergy
symptoms hold me back from
getting on and achieving all I
want to. Each year I’ve needed more
antihistamines to get through the
season.
Now that I’ve started AIT, could I
finally get control of my
symptoms and enjoy spring
spring comes around, my allergy
symptoms hold me back from
getting on and achieving all I
want to. Each year I’ve needed more
antihistamines to get through the
season.
Now that I’ve started AIT, could I
finally get control of my
symptoms and enjoy spring
Help her to love a life beyond allergy
Clinical History
For 5 years, rhinitis symptoms (frequent sneezing salvos, rhinorrhea, itchy nose and throat , itchy and red eyes, fatigue) occurring during Spring and early Summer time, with fatigue and irritability at work. She was treated with:
- Oral H1-antihistamines
- Cromoglycate eye drops
- Nasal corticosteroids
(which she presumably does not take)
Last year, for the first time, she complained of breath difficulties with diurnal wheezing after a week-end outdoors during the season and had to take inhaled salbutamol.
Clinical Exam
No congested nasal
mucosa and watery
secretions
No red conjunctiva
No wheeze
Diagnosis
Diagnosis:
Allergic rhinitis to grass
pollen associated mild asthma
Polysensitization to cat danders
Cross-reactivity with Cypress,
Parietaria (profilin)
pollen associated mild asthma
Polysensitization to cat danders
Cross-reactivity with Cypress,
Parietaria (profilin)
Treat
Physician
Recommendation
Recommendation
Symptomatic Treatment
Sublingual immunotherapy liquid formulation
Sublingual immunotherapy tablet formulation
Patient's Choice
Sublingual immunotherapy
tablet formulation
tablet formulation
Oralair® is the only grass pollen AIT
tablet with an established
discontinuous treatment protocol
tablet with an established
discontinuous treatment protocol
Initiate Treatment
Early results
“For the first time in years, spring feels
hopeful. I have been taking my AIT for 4
months leading up to the beginning of the
season. Now that it's here, even as the pollen
count rises, my symptoms reduce. This could
be my year. I'm going to put my best foot
forward - because I can now, without my
allergy holding me back.”
hopeful. I have been taking my AIT for 4
months leading up to the beginning of the
season. Now that it's here, even as the pollen
count rises, my symptoms reduce. This could
be my year. I'm going to put my best foot
forward - because I can now, without my
allergy holding me back.”
Maintenance
Maintained
Results
Results
“It’s been two years since I finished AIT and I’m loving my reduced
symptoms life. Ever since I said goodbye to those awful, stifling symptoms, I’ve been
thriving at work in every season, without setbacks. And guess what? Today we’re
celebrating my promotion. Springtime is my time now.”
Life beyond allergy
Back to journey
Every patientdeserves to live a life beyond allergy
Potential AIT benefits over time
Theoretical concept adapted from Spriggs K, et al (Eds). Fast Facts:
Respiratory Allergies. 2021. Basel: S Karger AR.
Oralair® is a sublingual immunotherapy
tablet with a flexible initiation protocol
to improve tolerability and encourage
individual patient adherence.1,4-7
tablet with a flexible initiation protocol
to improve tolerability and encourage
individual patient adherence.1,4-7
Highly potent, Oralair® demonstrated results as early
as 1 month7* and meaningful improvements over time for patients to a life beyond
allergy8,9
Oralair® has proven overlasting effects on the patient
health up to 6 years after treatment cessation11.
Let us tell you all about it
*Results of the secondary endpoints observed in the controlled conditions of an Allergen Challenge
Chamber (ACC). The single allergen
source, the lack of seasonal priming, subject demographics closed by the ACC area, trial context and short duration might not reflect the
natural pathological process and environmental factors contributing to an individual’s development of allergic rhinoconjunctivitis.
**In this study Oralair was investigated as one product in a treatment group compared to a control group and is based on a retrospective
database analysis of health and prescription data
source, the lack of seasonal priming, subject demographics closed by the ACC area, trial context and short duration might not reflect the
natural pathological process and environmental factors contributing to an individual’s development of allergic rhinoconjunctivitis.
**In this study Oralair was investigated as one product in a treatment group compared to a control group and is based on a retrospective
database analysis of health and prescription data
